You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Called Intervene, the project will use genomic and health data from biorepositories along with machine learning methods to develop new clinical predictive tools.
The African health technology company 54gene is eager for partnerships with researchers and biopharmaceutical companies alike.
The researchers also examined the contribution of rare variants to inflammatory bowel disease to find a potential targetable pathway.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
With the new funding, the informatics and small-panel genetic testing firm looks to expand its IT capabilities and offer new DTC screening tests.
UK Biobank hopes cloud-based analytics tools will streamline WGS analysis and open the database to researchers who don't otherwise have access to bioinformatics infrastructure.
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
Roche, Shionogi, Janssen Pharmaceuticals, and Eisai will provide the charity with specimens from Alzheimer's disease patients who participated in clinical studies.
The findings underscore the value of carrying out large-scale human genetic analyses as part of drug target identification and validation efforts.
The GWAS of more than 200,000 Japanese individuals across 42 diseases identified 25 novel loci shared between Japanese and European populations.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.